• OPEN AN ACCOUNT
Indian Indices
Sensex
83,919.71 897.96
( 1.08%)
Global Indices
Nasdaq
49,248.22 -970.95
(-1.93%)
Dow Jones
7,218.05 -126.58
(-1.72%)
Hang Seng
56,657.02 -2,787.19
(-4.69%)
Nikkei 225
10,468.58 -82.59
(-0.78%)
Forex
USD-INR
93.42 -0.12
(-0.13%)
EUR-INR
102.53 -0.37
(-0.36%)
GBP-INR
123.02 -0.43
(-0.35%)
JPY-INR
0.59 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Starlineps Enterprises Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
540492
INE594W01042
3.9313052
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
54.69
306.42
EPS(TTM)
Face Value()
Div & Yield %
0.13
1
0
 

US FDA issues warning letter to Alkem's Daman unit
Nov 19,2026

 Alkem Laboratories announced that the US FDA has issued a warning letter dated November 18, 2026 for Company's manufacturing facility located at Amaliya, Daman. The Company shall be responding to the US FDA within stipulated timeline.

The Company continues to manufacture and supply approved products from the said facility to the U.S. market.

Previously, the US FDA had conducted inspection of the this facility from 20 April  2026 to 01 May 2026. The US FDA had classified the inspection status of the said facility as Official Action Indicated (OAI).